ABCL
Price
$5.71
Change
+$0.02 (+0.35%)
Updated
Jul 31 closing price
Capitalization
1.74B
2 days until earnings call
Intraday BUY SELL Signals
ACET
Price
$9.11
Change
+$0.05 (+0.55%)
Updated
Jul 31 closing price
Capitalization
85.16M
3 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs ACET

ABCL vs ACET Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABCL vs. ACET commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and ACET is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (ABCL: $5.71 vs. ACET: $9.11)
Brand notoriety: ABCL and ACET are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 51% vs. ACET: 84%
Market capitalization -- ABCL: $1.74B vs. ACET: $85.16M
ABCL [@Biotechnology] is valued at $1.74B. ACET’s [@Biotechnology] market capitalization is $85.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileACET’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ACET’s FA Score: 1 green, 4 red.
According to our system of comparison, ACET is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while ACET’s TA Score has 6 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 7 bearish.
  • ACET’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ACET is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +7.53% price change this week, while ACET (@Biotechnology) price change was +16.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 05, 2026.

ACET is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.74B) has a higher market cap than ACET($85.2M). ABCL YTD gains are higher at: 66.959 vs. ACET (8.195). ACET has higher annual earnings (EBITDA): -102.73M vs. ABCL (-167.02M). ABCL has more cash in the bank: 505M vs. ACET (138M). ACET has less debt than ABCL: ACET (13.9M) vs ABCL (140M). ABCL has higher revenues than ACET: ABCL (79.2M) vs ACET (0).
ABCLACETABCL / ACET
Capitalization1.74B85.2M2,047%
EBITDA-167.02M-102.73M163%
Gain YTD66.9598.195817%
P/E RatioN/AN/A-
Revenue79.2M0-
Total Cash505M138M366%
Total Debt140M13.9M1,007%
FUNDAMENTALS RATINGS
ACET: Fundamental Ratings
ACET
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLACET
RSI
ODDS (%)
Bearish Trend 4 days ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
81%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
ACET
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MAYT39.170.22
+0.56%
AllianzIM US Equity Buffer10 May ETF
EDOG24.59-0.07
-0.30%
ALPS Emerging Sector Dividend Dogs ETF
TSYY20.23-0.06
-0.30%
GraniteShares YieldBOOST TSLA ETF
IGRO91.60-0.84
-0.91%
iShares International Dividend Gr ETF
SOFA11.96-0.16
-1.32%
Direxion Daily SOFI Bull 2X ETF

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+0.35%
RXRX - ABCL
62%
Loosely correlated
-1.32%
ABSI - ABCL
56%
Loosely correlated
+1.83%
CRSP - ABCL
56%
Loosely correlated
-0.93%
VCYT - ABCL
56%
Loosely correlated
-22.52%
EDIT - ABCL
54%
Loosely correlated
-4.09%
More

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with RXRX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
+0.55%
RXRX - ACET
45%
Loosely correlated
-1.32%
KURA - ACET
44%
Loosely correlated
-3.22%
VIR - ACET
42%
Loosely correlated
-2.70%
OGI - ACET
41%
Loosely correlated
-2.96%
ABCL - ACET
41%
Loosely correlated
+0.35%
More